These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3652053)

  • 41. Dibenzo[a,g]quinolizin-8-ones: synthesis, estrogen receptor affinities, and cytostatic activity.
    von Angerer S; Brandl G; Mannschreck A; Weimar C; Wiegrebe W
    Anticancer Drug Des; 1992 Oct; 7(5):351-63. PubMed ID: 1388628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Internalization of a C17α-alkynylestradiol-porphyrin conjugate into estrogen receptor positive MCF-7 breast cancer cells.
    Sadler S; Persons KS; Jones GB; Ray R
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4638-41. PubMed ID: 21704522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and biological evaluation of 2,3,4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer.
    Kumar S; Deshpande S; Chandra V; Kitchlu S; Dwivedi A; Nayak VL; Konwar R; Prabhakar YS; Sahu DP
    Bioorg Med Chem; 2009 Oct; 17(19):6832-40. PubMed ID: 19740667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological evaluation of a series of gem-dichlorocyclopropanes as antitumor agents.
    Griffin MT; Magarian RA; Jain P; Pento JT; Mousissian GK; Graves DC
    Anticancer Drug Des; 1992 Feb; 7(1):49-66. PubMed ID: 1543527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytotoxic activity of FK973 against human oral and breast cancer cells.
    Wu JZ; Adachi I; Watanabe T
    Chin Med J (Engl); 1991 Oct; 104(10):834-7. PubMed ID: 1661225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036.
    Tapiero H; Yin MB; Catalin J; Paraire M; Deloffre P; Rustum Y; Bizzari JP; Tew KD
    Anticancer Res; 1989; 9(6):1617-22. PubMed ID: 2627116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro pharmacodynamic assay for cancer drug development: application to crisnatol, a new DNA intercalator.
    Adams DJ
    Cancer Res; 1989 Dec; 49(23):6615-20. PubMed ID: 2819712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site.
    Murphy LC; Sutherland RL
    J Clin Endocrinol Metab; 1983 Aug; 57(2):373-9. PubMed ID: 6408114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents.
    Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
    Eur J Med Chem; 2014 Oct; 86():211-8. PubMed ID: 25164760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: part I.
    Caruso A; Chimento A; El-Kashef H; Lancelot JC; Panno A; Pezzi V; Saturnino C; Sinicropi MS; Sirianni R; Rault S
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):609-13. PubMed ID: 21883039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells.
    Drewinko B; Loo TL; Gottlieb JA
    Cancer Res; 1976 Feb; 36(2 Pt 1):511-5. PubMed ID: 1260749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytotoxic estrogens in hormone receptive tumors.
    Raus J; Martens H; Leclercq G
    J Toxicol Environ Health; 1981 Jan; 7(1):159-65. PubMed ID: 7265294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. (Arene)Cl₂Ru(II) complexes with N-coordinated estrogen and androgen isonicotinates: interaction with sex hormone binding globulin and anticancer activity.
    Schobert R; Seibt S; Effenberger-Neidnicht K; Underhill C; Biersack B; Hammond GL
    Steroids; 2011 Mar; 76(4):393-9. PubMed ID: 21184767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An estradiol-porphyrin conjugate selectively localizes into estrogen receptor-positive breast cancer cells.
    Swamy N; James DA; Mohr SC; Hanson RN; Ray R
    Bioorg Med Chem; 2002 Oct; 10(10):3237-43. PubMed ID: 12150869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
    Zeller WJ; Schreiber J; Petru E; Eisenbrand G
    Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation.
    Kelly PM; Keely NO; Bright SA; Yassin B; Ana G; Fayne D; Zisterer DM; Meegan MJ
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28858267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment.
    Wong MY; Chiu GN
    Anticancer Drugs; 2010 Apr; 21(4):401-10. PubMed ID: 20110806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cellular response to treatment with 4-(3-(2-chloroethyl)-3-nitrosoureido)-cis-cyclohexanecarboxylic acid, a water-soluble nitrosourea derivative.
    Drewinko B; Green C; Loo TL
    Cancer Treat Rep; 1977 Nov; 61(8):1513-8. PubMed ID: 922754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The activity of locally applied cytotoxics to breast cancer cells in vitro.
    Park KG; Chetty U; Scott W; Miller W
    Ann R Coll Surg Engl; 1991 Mar; 73(2):96-9. PubMed ID: 1708217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bis-arylidene oxindoles as anti-breast-cancer agents acting via the estrogen receptor.
    Pal A; Ganguly A; Ghosh A; Yousuf M; Rathore B; Banerjee R; Adhikari S
    ChemMedChem; 2014 Apr; 9(4):727-32. PubMed ID: 24482362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.